Tacrolimus Ointment - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509240991

Publication Date:

September 6, 2024

Pages:

106

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Tacrolimus ointment is a topical drug (a drug that is applied to the skin) that is used for the treatment of atopic dermatitis (eczema). Atopic dermatitis is a chronic (long-lasting) disease of skin in which the skin becomes inflamed, causing itchiness, redness, swelling, cracking, weeping, crusting, and scaling. The inflammation is caused by activation of the immune system though the reason for the activation is unknown. Tacrolimus ointment suppresses the immune system and the inflammation by inhibiting an enzyme (calcineurin) crucial for the multiplication of T-cells, cells that are required for activation of the immune system. Tacrolimus ointment was approved for the treatment of atopic dermatitis in December 2000.
The global market for Tacrolimus Ointment was estimated to be worth US$ 365 million in 2023 and is forecast to a readjusted size of US$ 543.5 million by 2030 with a CAGR of 6.1% during the forecast period 2024-2030
North American market for Tacrolimus Ointment was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tacrolimus Ointment was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Tacrolimus Ointment was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Tacrolimus Ointment include LEO Pharma, Sandoz, Glenmark, Zhejiang Wansheng Pharmaceutical, North China Pharmaceutical Company, Humanwell, Sichuan Med-Shine Pharmaceutical and IVA HEALTHCARE, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tacrolimus Ointment, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Tacrolimus Ointment by region & country, by Type, and by Application.
The Tacrolimus Ointment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tacrolimus Ointment.
麻豆原创 Segmentation
By Company
LEO Pharma
Sandoz
Glenmark
Zhejiang Wansheng Pharmaceutical
North China Pharmaceutical Company
Humanwell
Sichuan Med-Shine Pharmaceutical
IVA HEALTHCARE
Segment by Type:
Ointment 0.1%
Ointment 0.03%
Segment by Application
Adult
Kids
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Tacrolimus Ointment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Tacrolimus Ointment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Tacrolimus Ointment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Tacrolimus Ointment Product Introduction
1.2 Global Tacrolimus Ointment 麻豆原创 Size Forecast
1.2.1 Global Tacrolimus Ointment Sales Value (2019-2030)
1.2.2 Global Tacrolimus Ointment Sales Volume (2019-2030)
1.2.3 Global Tacrolimus Ointment Sales Price (2019-2030)
1.3 Tacrolimus Ointment 麻豆原创 Trends & Drivers
1.3.1 Tacrolimus Ointment Industry Trends
1.3.2 Tacrolimus Ointment 麻豆原创 Drivers & Opportunity
1.3.3 Tacrolimus Ointment 麻豆原创 Challenges
1.3.4 Tacrolimus Ointment 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Tacrolimus Ointment Players Revenue Ranking (2023)
2.2 Global Tacrolimus Ointment Revenue by Company (2019-2024)
2.3 Global Tacrolimus Ointment Players Sales Volume Ranking (2023)
2.4 Global Tacrolimus Ointment Sales Volume by Company Players (2019-2024)
2.5 Global Tacrolimus Ointment Average Price by Company (2019-2024)
2.6 Key Manufacturers Tacrolimus Ointment Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Tacrolimus Ointment Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Tacrolimus Ointment
2.9 Tacrolimus Ointment 麻豆原创 Competitive Analysis
2.9.1 Tacrolimus Ointment 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Tacrolimus Ointment Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tacrolimus Ointment as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Ointment 0.1%
3.1.2 Ointment 0.03%
3.2 Global Tacrolimus Ointment Sales Value by Type
3.2.1 Global Tacrolimus Ointment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Tacrolimus Ointment Sales Value, by Type (2019-2030)
3.2.3 Global Tacrolimus Ointment Sales Value, by Type (%) (2019-2030)
3.3 Global Tacrolimus Ointment Sales Volume by Type
3.3.1 Global Tacrolimus Ointment Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Tacrolimus Ointment Sales Volume, by Type (2019-2030)
3.3.3 Global Tacrolimus Ointment Sales Volume, by Type (%) (2019-2030)
3.4 Global Tacrolimus Ointment Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Adult
4.1.2 Kids
4.2 Global Tacrolimus Ointment Sales Value by Application
4.2.1 Global Tacrolimus Ointment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Tacrolimus Ointment Sales Value, by Application (2019-2030)
4.2.3 Global Tacrolimus Ointment Sales Value, by Application (%) (2019-2030)
4.3 Global Tacrolimus Ointment Sales Volume by Application
4.3.1 Global Tacrolimus Ointment Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Tacrolimus Ointment Sales Volume, by Application (2019-2030)
4.3.3 Global Tacrolimus Ointment Sales Volume, by Application (%) (2019-2030)
4.4 Global Tacrolimus Ointment Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Tacrolimus Ointment Sales Value by Region
5.1.1 Global Tacrolimus Ointment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Tacrolimus Ointment Sales Value by Region (2019-2024)
5.1.3 Global Tacrolimus Ointment Sales Value by Region (2025-2030)
5.1.4 Global Tacrolimus Ointment Sales Value by Region (%), (2019-2030)
5.2 Global Tacrolimus Ointment Sales Volume by Region
5.2.1 Global Tacrolimus Ointment Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Tacrolimus Ointment Sales Volume by Region (2019-2024)
5.2.3 Global Tacrolimus Ointment Sales Volume by Region (2025-2030)
5.2.4 Global Tacrolimus Ointment Sales Volume by Region (%), (2019-2030)
5.3 Global Tacrolimus Ointment Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Tacrolimus Ointment Sales Value, 2019-2030
5.4.2 North America Tacrolimus Ointment Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Tacrolimus Ointment Sales Value, 2019-2030
5.5.2 Europe Tacrolimus Ointment Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Tacrolimus Ointment Sales Value, 2019-2030
5.6.2 Asia Pacific Tacrolimus Ointment Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Tacrolimus Ointment Sales Value, 2019-2030
5.7.2 South America Tacrolimus Ointment Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Tacrolimus Ointment Sales Value, 2019-2030
5.8.2 Middle East & Africa Tacrolimus Ointment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Tacrolimus Ointment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Tacrolimus Ointment Sales Value
6.2.1 Key Countries/Regions Tacrolimus Ointment Sales Value, 2019-2030
6.2.2 Key Countries/Regions Tacrolimus Ointment Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Tacrolimus Ointment Sales Value, 2019-2030
6.3.2 United States Tacrolimus Ointment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Tacrolimus Ointment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Tacrolimus Ointment Sales Value, 2019-2030
6.4.2 Europe Tacrolimus Ointment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Tacrolimus Ointment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Tacrolimus Ointment Sales Value, 2019-2030
6.5.2 China Tacrolimus Ointment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Tacrolimus Ointment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Tacrolimus Ointment Sales Value, 2019-2030
6.6.2 Japan Tacrolimus Ointment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Tacrolimus Ointment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Tacrolimus Ointment Sales Value, 2019-2030
6.7.2 South Korea Tacrolimus Ointment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Tacrolimus Ointment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Tacrolimus Ointment Sales Value, 2019-2030
6.8.2 Southeast Asia Tacrolimus Ointment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Tacrolimus Ointment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Tacrolimus Ointment Sales Value, 2019-2030
6.9.2 India Tacrolimus Ointment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Tacrolimus Ointment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 LEO Pharma
7.1.1 LEO Pharma Company Information
7.1.2 LEO Pharma Introduction and Business Overview
7.1.3 LEO Pharma Tacrolimus Ointment Sales, Revenue and Gross Margin (2019-2024)
7.1.4 LEO Pharma Tacrolimus Ointment Product Offerings
7.1.5 LEO Pharma Recent Development
7.2 Sandoz
7.2.1 Sandoz Company Information
7.2.2 Sandoz Introduction and Business Overview
7.2.3 Sandoz Tacrolimus Ointment Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Sandoz Tacrolimus Ointment Product Offerings
7.2.5 Sandoz Recent Development
7.3 Glenmark
7.3.1 Glenmark Company Information
7.3.2 Glenmark Introduction and Business Overview
7.3.3 Glenmark Tacrolimus Ointment Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Glenmark Tacrolimus Ointment Product Offerings
7.3.5 Glenmark Recent Development
7.4 Zhejiang Wansheng Pharmaceutical
7.4.1 Zhejiang Wansheng Pharmaceutical Company Information
7.4.2 Zhejiang Wansheng Pharmaceutical Introduction and Business Overview
7.4.3 Zhejiang Wansheng Pharmaceutical Tacrolimus Ointment Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Zhejiang Wansheng Pharmaceutical Tacrolimus Ointment Product Offerings
7.4.5 Zhejiang Wansheng Pharmaceutical Recent Development
7.5 North China Pharmaceutical Company
7.5.1 North China Pharmaceutical Company Company Information
7.5.2 North China Pharmaceutical Company Introduction and Business Overview
7.5.3 North China Pharmaceutical Company Tacrolimus Ointment Sales, Revenue and Gross Margin (2019-2024)
7.5.4 North China Pharmaceutical Company Tacrolimus Ointment Product Offerings
7.5.5 North China Pharmaceutical Company Recent Development
7.6 Humanwell
7.6.1 Humanwell Company Information
7.6.2 Humanwell Introduction and Business Overview
7.6.3 Humanwell Tacrolimus Ointment Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Humanwell Tacrolimus Ointment Product Offerings
7.6.5 Humanwell Recent Development
7.7 Sichuan Med-Shine Pharmaceutical
7.7.1 Sichuan Med-Shine Pharmaceutical Company Information
7.7.2 Sichuan Med-Shine Pharmaceutical Introduction and Business Overview
7.7.3 Sichuan Med-Shine Pharmaceutical Tacrolimus Ointment Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Sichuan Med-Shine Pharmaceutical Tacrolimus Ointment Product Offerings
7.7.5 Sichuan Med-Shine Pharmaceutical Recent Development
7.8 IVA HEALTHCARE
7.8.1 IVA HEALTHCARE Company Information
7.8.2 IVA HEALTHCARE Introduction and Business Overview
7.8.3 IVA HEALTHCARE Tacrolimus Ointment Sales, Revenue and Gross Margin (2019-2024)
7.8.4 IVA HEALTHCARE Tacrolimus Ointment Product Offerings
7.8.5 IVA HEALTHCARE Recent Development
8 Industry Chain Analysis
8.1 Tacrolimus Ointment Industrial Chain
8.2 Tacrolimus Ointment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Tacrolimus Ointment Sales Model
8.5.2 Sales Channel
8.5.3 Tacrolimus Ointment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

LEO Pharma
Sandoz
Glenmark
Zhejiang Wansheng Pharmaceutical
North China Pharmaceutical Company
Humanwell
Sichuan Med-Shine Pharmaceutical
IVA HEALTHCARE

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.